1. Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity;Acuña;Pharmacogenomics J.,2002
2. Placebo controls in short-term clinical trials of hypertension;Al-Khatib;Science,2001
3. Association of American Universities 2000 Task Force on Research Accountability: Report on University Protection of Human Beings Who Are the Subjects of Research Washington, DC www.aau.edu/HumSUbRpt06.28.00pdf
4. Biomarkers and surrogate endpoints: preferred definitions and conceptual frameworks;Biomarkers Definitions Working Group;Clin. Pharmacol. Ther.,2001
5. Bohazchuk W. 1998 Ethics committee and IRB audit results Good Clinical Practice 46 55